Kevin Coop - Jun 24, 2024 Form 4 Insider Report for Definitive Healthcare Corp. (DH)

Role
Chief Executive Officer, Director
Signature
/s/ Matthew Ruderman, Attorney-in-Fact
Stock symbol
DH
Transactions as of
Jun 24, 2024
Transactions value $
$0
Form type
4
Date filed
6/24/2024, 06:31 PM
Previous filing
Mar 14, 2022
Next filing
Jul 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DH Class A Common Stock Award $0 +1.17M $0.00 1.17M Jun 24, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DH Performance-based Stock Units Award $0 +1.14M $0.00 1.14M Jun 24, 2024 Class A Common Stock 1.14M Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001 (the "Class A Common Stock"), with 25% of the RSUs vesting on July 1, 2025, followed by vesting of 6.25% every three months thereafter over the subsequent three years, subject to the Reporting Person's continued service with the Issuer through each such vesting date.
F2 Represents performance-based stock units ("PSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, which will vest in four tranches: (i) 200,000 PSUs are subject to the first vesting tranche, (ii) 266,667 PSUs are subject to the second vesting tranche, (iii) 300,000 PSUs are subject to the third vesting tranche, and (iv) 370,371 PSUs are subject to the fourth vesting tranche. The first vesting tranche will vest during a two-year performance period beginning on the grant date and the other three vesting tranches will vest during a four-year performance period beginning on the grant date (each, a "Performance Period"). Each vesting tranche is subject to satisfaction of certain stock price hurdles and a continued service requirement.
F3 Footnote continued: The stock price hurdle for a particular vesting tranche will be satisfied if, during the applicable Performance Period, the average closing price of the Class A Common Stock is at least, for 30 consecutive trading days, (i) $10.00 with respect to the first vesting tranche, (ii) $15.00 with respect to the second vesting tranche, (iii) $20.00 with respect to the third vesting tranche and (iv) $27.00 with respect to the fourth vesting tranche. The vesting date for a particular vesting tranche will be the date on which the Human Capital Management and Compensation Committee of the Board certifies that the applicable stock price hurdle has been achieved with respect to such vesting tranche (the "PSU Vesting Date"). For the continued service requirement to be satisfied with respect to a particular vesting tranche, the Reporting Person must remain in continued service through each PSU Vesting Date.